Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock.Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Marco Zingaro
…
This content is for Standard 1 Year members only. LoginJoin Now